Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for carotid body resection and carotid body denervation, with an effective date of May 15, 2026. Here's what billing teams need to know before claims start moving through the system.
CMS carotid body resection coverage policy changes don't happen often, and when they do, the financial exposure is real. This procedure sits at the intersection of cardiovascular surgery and interventional technique — and CMS has historically treated it with skepticism. The modification signals that the agency is drawing clearer lines around what it will and won't pay for. Your billing team needs to understand where those lines fall before May 15, 2026.
The policy does not list specific CPT, HCPCS, or ICD-10 codes in the available documentation. We'll address what that means for your charge capture and claim submissions below.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Carotid Body Resection / Carotid Body Denervation |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Vascular surgery, cardiovascular surgery, interventional cardiology, cardiac electrophysiology |
| Key Action | Confirm your MAC's local coverage determination for this procedure before submitting claims after May 15, 2026 |
CMS Carotid Body Resection Coverage Criteria and Medical Necessity Requirements 2026
The core issue with carotid body resection and carotid body denervation is that CMS has long treated these procedures with caution. The carotid body is a small chemoreceptor organ at the bifurcation of the common carotid artery. Resecting or denervating it has been explored as a treatment for conditions like resistant hypertension and heart failure. That clinical backstory matters because it shapes how CMS evaluates medical necessity.
CMS coverage policy modifications in this space typically tighten — not loosen — the criteria. When the agency modifies a policy for a procedure this specialized, it usually means the evidence threshold has shifted. Billing teams should expect stricter medical necessity documentation requirements, not broader coverage.
The available policy documentation does not include specific published coverage criteria at this time. That's a problem for billing teams, and it's worth saying plainly: if your MAC hasn't issued a corresponding local coverage determination, you're working with incomplete information. Contact your Medicare Administrative Contractor directly before May 15, 2026, to confirm what documentation standards your region will apply.
Prior authorization is not universally required across all Medicare fee-for-service claims, but for a procedure this clinically narrow, your MAC may impose additional scrutiny. If you treat patients through Medicare Advantage plans, check each plan's prior authorization requirements separately — MA plans set their own rules on top of CMS's baseline coverage policy.
Medical necessity is the linchpin here. For any claim involving carotid body resection or carotid body denervation, your documentation needs to clearly establish the clinical rationale, the diagnosis driving the procedure, and why less invasive alternatives were considered and rejected. Without that, the claim denial risk is high.
CMS Carotid Body Resection Exclusions and Non-Covered Indications
CMS has historically classified carotid body denervation for certain investigational indications — particularly heart failure and resistant hypertension without strong Level I evidence — as experimental or not medically necessary. That classification matters for reimbursement because claims submitted for non-covered indications will be denied regardless of the procedure's technical success.
The modified policy may expand or contract which indications CMS considers supported by evidence. Until the full policy text is available through your MAC or the CMS coverage database, treat any carotid body resection claim for an off-label or investigational indication as high-risk. Document aggressively or hold the claim until you have clarity.
If your practice has been submitting these claims under an assumption of coverage, audit those submissions now. A coverage policy change with a defined effective date creates a clean before/after line. Claims submitted after May 15, 2026, under old assumptions are exposure you can control.
Coverage Indications at a Glance
Because the policy documentation does not include specific indication-level criteria at this time, a full coverage indications table cannot be built from verified data. The table below reflects what is known from the procedure's clinical history and CMS's general approach to this class of procedure. Confirm every row against your MAC's LCD before submitting claims.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Carotid body resection (surgical) | Unconfirmed pending full policy text | Not listed in policy data | Verify with your MAC before May 15, 2026 |
| Carotid body denervation (interventional) | Unconfirmed pending full policy text | Not listed in policy data | Historically treated as investigational by many MACs |
| Resistant hypertension — carotid body as target | Likely not covered / experimental | Not listed in policy data | Limited Level I evidence; high denial risk |
| Heart failure — carotid body denervation | Likely not covered / experimental | Not listed in policy data | CMS has not recognized this as a covered indication historically |
This table will be updated when CMS releases the full policy text. Check the source policy at app.payerpolicy.org for version updates.
CMS Carotid Body Resection Billing Guidelines and Action Items 2026
The absence of specific codes in the published policy data is not a reason to wait. Here's what your billing team should do now.
| # | Action Item |
|---|---|
| 1 | Contact your MAC immediately. Ask specifically whether a local coverage determination accompanies this CMS modification. MACs often publish LCDs in parallel with national policy changes. Get a written response or case number. Do this before April 1, 2026, to give yourself time to act before the effective date. |
| 2 | Audit claims submitted in the past 12 months for any carotid body resection or denervation procedures. Identify the CPT codes your surgeons used, the ICD-10 diagnosis codes attached, and whether any were denied. This gives you a baseline to measure against the new policy and flags any patterns that could create exposure going forward. |
| 3 | Build a documentation checklist for medical necessity. At minimum, it should capture: the primary diagnosis, the evidence of treatment failure for less invasive alternatives, the surgeon's documented clinical rationale, and any supporting literature cited. Every carotid body resection billing submission after May 15, 2026, should have this checklist attached to the chart. |
| 4 | Check all Medicare Advantage plans separately. The CMS modification sets the baseline, but every MA plan you contract with can set tighter rules. Pull the prior authorization requirements for carotid body procedures from each MA plan's portal before May 15, 2026. If a plan requires prior auth and you don't have it, the claim denial is automatic. |
| 5 | Flag this procedure in your charge capture workflow. Until you have confirmed CPT codes from the full policy text and your MAC's LCD, tag carotid body resection and denervation as requiring compliance review before submission. Your billing team should not submit these claims on autopilot after the effective date. |
| 6 | Loop in your compliance officer. This is exactly the kind of policy change — modification with no listed codes, a procedure with investigational history, and a tight effective date — that creates quiet exposure. Your compliance officer should know this change is live and that you're auditing submissions. If your practice does significant volume in vascular or cardiovascular surgery, ask them whether a formal risk assessment is warranted. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Carotid Body Resection and Denervation Under This Policy
The policy documentation provided does not list specific CPT, HCPCS, or ICD-10 codes. This is not typical for a CMS coverage modification and is a significant gap for carotid body resection billing teams.
Do not use codes from this post or any secondary source as your billing authority. The risk of submitting under the wrong CPT code for a procedure this clinically specific is a claim denial at best and a compliance flag at worst.
What to Do Instead
Contact your MAC and ask for the specific CPT codes they expect for carotid body resection (surgical) and carotid body denervation (interventional or percutaneous approaches). Vascular surgery procedures in this anatomical region often bill under unlisted procedure codes when a specific CPT code doesn't exist — and that creates an additional layer of documentation requirements.
Your vascular or cardiovascular surgeon should also be part of this conversation. The correct CPT code depends on the specific surgical approach used. An unlisted CPT code submitted without a detailed operative report and a comparable procedure reference will be denied or returned for additional information.
This post will be updated when CMS publishes the full policy text with associated codes. Monitor the source policy at app.payerpolicy.org for version changes.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.